J Martin Carroll - Net Worth and Insider Trading
J Martin Carroll Net Worth
The estimated net worth of J Martin Carroll is at least $120,663 dollars as of 2024-11-05. J Martin Carroll is the Director of Esperion Therapeutics Inc and owns about 36,500 shares of Esperion Therapeutics Inc (ESPR) stock worth over $77,380. J Martin Carroll is the Director of Rocket Pharmaceuticals Inc and owns about 2,500 shares of Rocket Pharmaceuticals Inc (RCKT) stock worth over $42,975. J Martin Carroll is also the Director of TherapeuticsMD Inc and owns about 200 shares of TherapeuticsMD Inc (TXMD) stock worth over $308. Besides these, J Martin Carroll also holds Mallinckrodt PLC (MNKKQ) . Details can be seen in J Martin Carroll's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that J Martin Carroll has not made any transactions after 2023-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of J Martin Carroll
J Martin Carroll Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, J Martin Carroll owns 7 companies in total, including Catalent Inc (CTLT) , TherapeuticsMD Inc (TXMD) , and Mallinckrodt PLC (MNKKQ) among others .
Click here to see the complete history of J Martin Carroll’s form 4 insider trades.
Insider Ownership Summary of J Martin Carroll
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTLT | Catalent Inc | 2016-08-24 | director |
| TXMD | TherapeuticsMD Inc | 2015-05-08 | director |
| MNKKQ | Mallinckrodt PLC | 2022-06-16 | director |
 | | 2016-05-13 | director |
| | 2013-08-14 | director |
| | 2023-05-11 | director |
| | 2022-06-16 | director |
J Martin Carroll Latest Holdings Summary
J Martin Carroll currently owns a total of 4 stocks. Among these stocks, J Martin Carroll owns 36,500 shares of Esperion Therapeutics Inc (ESPR) as of May 11, 2023, with a value of $77,380 and a weighting of 64.13%. J Martin Carroll owns 2,500 shares of Rocket Pharmaceuticals Inc (RCKT) as of May 13, 2016, with a value of $42,975 and a weighting of 35.62%. J Martin Carroll also owns 200 shares of TherapeuticsMD Inc (TXMD) as of May 8, 2015, with a value of $308 and a weighting of 0.26%. The other 1 stocks Mallinckrodt PLC (MNKKQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of J Martin Carroll
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2023-05-11 | 36,500 | 2.12 | 77,380 |
| RCKT | Rocket Pharmaceuticals Inc | 2016-05-13 | 2,500 | 17.19 | 42,975 |
| TXMD | TherapeuticsMD Inc | 2015-05-08 | 200 | 1.54 | 308 |
| MNKKQ | Mallinckrodt PLC | 2021-03-12 | 0 | 0.02 | 0 |
Holding Weightings of J Martin Carroll
J Martin Carroll Form 4 Trading Tracker
According to the SEC Form 4 filings, J Martin Carroll has made a total of 1 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 31,500 shares on May 11, 2023, which cost J Martin Carroll around $48,825.
According to the SEC Form 4 filings, J Martin Carroll has made a total of 0 transactions in Rocket Pharmaceuticals Inc (RCKT) over the past 5 years. The most-recent trade in Rocket Pharmaceuticals Inc is the acquisition of 2,500 shares on May 13, 2016, which cost J Martin Carroll around $90,300.
According to the SEC Form 4 filings, J Martin Carroll has made a total of 0 transactions in TherapeuticsMD Inc (TXMD) over the past 5 years. The most-recent trade in TherapeuticsMD Inc is the acquisition of 200 shares on May 8, 2015, which cost J Martin Carroll around $61,100.
More details on J Martin Carroll's insider transactions can be found in the Insider Trading History of J Martin Carroll table.Insider Trading History of J Martin Carroll
- 1
J Martin Carroll Trading Performance
GuruFocus tracks the stock performance after each of J Martin Carroll's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by J Martin Carroll is -5.95%. GuruFocus also compares J Martin Carroll's trading performance to market benchmark return within the same time period. The performance of stocks bought by J Martin Carroll within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how J Martin Carroll's insider trading performs compared to the benchmark.
Performance of J Martin Carroll
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.79 | | | | | |
| Relative Return to S&P 500(%) | 0.16 | | | | | |
J Martin Carroll Ownership Network
Ownership Network List of J Martin Carroll
Ownership Network Relation of J Martin Carroll
J Martin Carroll Owned Company Details
What does Catalent Inc do?
Who are the key executives at Catalent Inc?
J Martin Carroll is the director of Catalent Inc. Other key executives at Catalent Inc include SVP & General Counsel & CCO Joseph Anthony Ferraro , Group President & Biologics David Mcerlane , and SVP & Chief HR Officer Lisa Evoli .
Catalent Inc (CTLT) Insider Trades Summary
Over the past 18 months, J Martin Carroll made no insider transaction in Catalent Inc (CTLT). Other recent insider transactions involving Catalent Inc (CTLT) include a net sale of 2,740 shares made by Ricky Hopson , a net sale of 1,795 shares made by Scott Gunther , and a net sale of 2,195 shares made by Aristippos Gennadios .
In summary, during the past 3 months, insiders sold 2,314 shares of Catalent Inc (CTLT) in total and bought 0 shares, with a net sale of 2,314 shares. During the past 18 months, 34,661 shares of Catalent Inc (CTLT) were sold and 22,000 shares were bought by its insiders, resulting in a net sale of 12,661 shares.
Catalent Inc (CTLT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalent Inc Insider Transactions
J Martin Carroll Mailing Address
Above is the net worth, insider trading, and ownership report for J Martin Carroll. You might contact J Martin Carroll via mailing address: C/o Catalent, Inc., 14 Schoolhouse Road, Somerset Nj 08873.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
